Posts by: Alice Melão

The U.S. Food and Drug Administration (FDA) has approved Imbruvica (ibrutinib) for the treatment of chronic graft-versus-host-disease (cGVHD), a common complication of stem cell or bone marrow transplant, in adult patients ... Read more

July 31, 2017July 31, 2017

STRO-001 Eliminates or Slows Growth of Myeloma and Lymphoma in Mice, Studies Show

News

Sutro Biopharma‘s STRO-001 eliminates or significantly slows the growth of non-Hodgkin lymphoma and multiple myeloma tumors, studies in mice indicate. Sutro expects the results to support its investigational new drug application for ... Read more

June 2, 2017

Adding Darzalex to Standard Therapies in Multiple Myeloma Patients Continues to Show Improved Results

News

Adding Darzalex (daratumumab) to standard care therapies continues to show improved effectiveness in treating relapsed or refractory multiple myeloma, with no related toxicity, according to updated results from the ongoing Phase 3 ... Read more

May 8, 2017May 8, 2017

One World Cannabis to Test Mice in Pursuit of Therapies Targeting Multiple Myeloma Cancer Cells

News

Israel’s One World Cannabis (OWC) says it’s moving forward to mouse models to test its unique formula of cannabinoid-based therapies targeting cancer cells. This decision followed promising results from preclinical in vitro studies. ... Read more

May 5, 2017May 22, 2017

Darzalex Approved in Europe as Combo Therapy for Advanced Multiple Myeloma

News

Janssen’s Darzalex (daratumumab) received full approval by the European Commission (EC) for use in treating adult patients with multiple myeloma who have received at least one prior therapy. The EC approved ... Read more

March 22, 2017March 22, 2017

BioLineRx’s BL-8040 Shows Promise in Bone Marrow Transplants for Blood Cancers

News

BioLineRx’s investigational drug BL-8040 has demonstrated positive interim results from a Phase 2 trial as a monotherapy for the mobilization and collection of donor blood stem cells for bone marrow ... Read more

March 1, 2017

Letermovir Prevents CMV Infection, Improves Survival in Bone Marrow Transplant Patients

News

Patients undergoing hematopoietic (donor) stem cell transplants could benefit from treatment with the experimental drug letermovir, which prevents the common viral infection cytomegalovirus (CMV). These results may help improve the ... Read more

Posts by: Alice Melão

Alice Melão

Imbruvica Becomes 1st FDA-Approved Therapy for Graft-Versus-Host-Disease in Adults

STRO-001 Eliminates or Slows Growth of Myeloma and Lymphoma in Mice, Studies Show

Adding Darzalex to Standard Therapies in Multiple Myeloma Patients Continues to Show Improved Results

One World Cannabis to Test Mice in Pursuit of Therapies Targeting Multiple Myeloma Cancer Cells

Darzalex Approved in Europe as Combo Therapy for Advanced Multiple Myeloma

BioLineRx’s BL-8040 Shows Promise in Bone Marrow Transplants for Blood Cancers

Letermovir Prevents CMV Infection, Improves Survival in Bone Marrow Transplant Patients

Most Popular Myeloma Articles This Month